Skip to main content
Clinical Trials/ITMCTR2100004656
ITMCTR2100004656
Recruiting
未知

Clinical Randomized Controlled Trial Study on Intervention of Electroacupuncture on Postpartum Rectus Abdominis Separation

Guangxing Hospital Affiliated to Zhejiang University of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Guangxing Hospital Affiliated to Zhejiang University of Traditional Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
Female

Investigators

Sponsor
Guangxing Hospital Affiliated to Zhejiang University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • (1\) Female 18\-45 years old, no history of pathological rectus abdominis separation;
  • (2\) Normal delivery, 42 days to 6 months after delivery;
  • (3\) Diagnosis of DRA (measurement method: The patient lies in supine position, with both knees bent approximately 90 degrees, the whole body is relaxed, and the soles of the feet are flat. The examiner places the fingertips of one hand on the level of the patient's umbilicus; Breathe, lift your head and shoulders away from the bed while exhaling, so that the abdominal muscles contract, the examiner's fingers are gently pressed down, numbers of fingers that can hold is the distance between the two rectus abdominis muscles. Measure the width of the fingers inserted by the examiner, and the rectus abdominis distance \>\= 2cm is diagnosed as DRA); at the end of the treatment, evaluate the exercise training group (n \= 58\) to complete the data collection and perform data statistics.) The number of cases excluded from the evaluation of disease efficacy, safety evaluation, non\-compliance with the inclusion criteria/rejection of evaluation, etc. were included in the study subjects recruited subjects were randomly divided into 2 groups after baseline assessment at Hangzhou Clinical Center, Guangzhou Clinical Center, and Hechi Clinical Center.
  • (4\) No cognitive impairment, able to understand and communicate correctly;
  • (5\) Have not received DRA treatment in other hospitals or institutions;
  • (6\) Sign the informed consent, cooperate with the treatment, and can persist in completing all treatments as planned.
  • Note: Patients who meet the above 6 items at the same time can be included in this study.

Exclusion Criteria

  • (1\) Suspected or confirmed severe spinal disease (spinal fracture, metastasis, inflammatory or infectious disease, cauda equina syndrome/extensive neurological disease) and nerve damage;
  • (2\) Exercise contraindications such as fractures, severe heart disease, hypertension, cancer, etc. or serious infectious diseases;
  • (3\) Any surgery plan in the near future;
  • (4\) History of cesarean section;
  • (5\) A history of surgery on the abdomen.
  • Note: Anyone that meets any of the above should be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials